Hosted on MSN1mon
Globus Medical strengthens SCS market position with $250m Nevro dealFollowing strong financial results revealed last month, US-headquartered Globus Medical has agreed to acquire spinal cord stimulation (SCS) company Nevro for $250m to reinforce its position in the ...
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback